Nephron Sc Inc recalls Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, USP 11.25), 30x0.5 mL Sterile Vials each…

Recall date

January 13, 2023

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0175-2023

FDA classification

Class II

Brand / firm

Nephron Sc Inc

Sold / distributed

Nationwide within the United States including Puerto Rico. Guatamala

Why it was recalled

Short Fill

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, USP 11.25), 30x0.5 mL Sterile Vials each in a foil pouch, NDC 0487-2784-01 UPC 3 04872 78401 4